TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 10, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 3
- 0 vs. Q1 2023
- Portfolio value
- $110.7M
- −$29.2M (−20.9%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TNGXTango Therapeutics, Inc. | COM | 19,363,975 | $64.3M | 58.1% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,132,867 | $38.6M | 34.9% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 2,343,154 | $7.73M | 7.0% | 00.0% | Unchanged | History |